Enrique Miranda
Recombinant Antibody Technology (United Kingdom)(GB)University College London(GB)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, Immune Cell Function and Interaction, CAR-T cell therapy research, Immunotherapy and Immune Responses
Most-Cited Works
- → Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors(2017)425 cited
- → A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy(2015)239 cited
- → Induction of p53 protein expression by sodium arsenite(1997)89 cited
- → Development of the designed ankyrin repeat protein (DARPin) G3 for HER2 molecular imaging(2014)88 cited
- → Acid-cleavable thiomaleamic acid linker for homogeneous antibody–drug conjugation(2013)72 cited
- → Oncolytic Adenoviral Mutants with E1B19K Gene Deletions Enhance Gemcitabine-induced Apoptosis in Pancreatic Carcinoma Cells and Anti-Tumor Efficacy In vivo(2009)69 cited